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termination. CONCLUSIONS: Clinical trial learning curves have significant impli-
cations for outcomes research accuracy, patient safety, and overall trial success.
Clinical trial simulation may provide a broadly applicable methodology for ad-
dressing several factors associated with clinical trial learning curve effects and for
improving the accuracy of clinical trial outcomes.
PHP75
USE OF ELECTRONIC MEDICAL RECORDS FROM 2001 THROUGH 2010:
IMPLICATIONS FOR COMPARATIVE EFFECTIVENESS RESEARCH
Anastassopoulos KP1, Mann R2, Knight TG1, Sudharshan L1, Ackerman SJ2
1Covance Market Access Services, Inc., Gaithersburg, MD, USA, 2Covance Market Access
Services, Inc., San Diego, CA, USA
OBJECTIVES: Recent developments in the United States (US) health care reform
and funding for comparative effectiveness research suggest that use of electronic
medical records (EMR) in outcomes research may increase over time. EMR can be
particularly useful when outcomes are not well-defined with diagnosis or proce-
dures codes or when clinical data are needed. The objective of this study was to
review trends in the use of EMR during the past decade. METHODS: A review of
published literature was conducted in PubMed for years 2001 through 2010 to iden-
tify outcomes studies in the US that used EMR. Internal quality assurance studies
and validation studies that used EMR were excluded. The number of studies, set-
ting of care, patient population,whether the studywas comparative, and anynoted
limitationswere examined. RESULTS:A total of 58 EMR-based, outcomes studies in
the USwere identified over the past decade; increasing from 3 in 2001 to 12 in 2010.
The majority of studies included outpatient EMR. Studies included a variety of
patient populations with over one-third in cardiovascular disease, psychiatric dis-
ease, and diabetes combined. The percent of studies that were comparative ranged
from 0% in 2001 to 45% in 2010. Measures of effectiveness varied widely and in-
cluded lab values, clinical measures, and health-related quality-of-life outcomes.
Some noted limitations on the use of EMR data in outcomes research included lack
of representativeness of all care delivered across practice settings, lack of general-
izability and standardization, and reliance on health care provider reporting.
CONCLUSIONS: Although the use of EMR in outcomes research has increased
slowly in the past decade, the proportion of comparative studies using EMR has
increased over time. As the industry works to standardize EMR andmore advanced
outcomes are collected in EMR systems, EMR data may play a larger role in com-
parative effectiveness research.
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OBJECTIVES: In recent years, comparative effectiveness research (CER) has gained
increasing interest and investment across major life science and health policy
stakeholder groups: regulators, biopharmaceuticals, physicians, patients, and pay-
ers. Onemethod, large simple trial (LST), a hybrid of observational cohort study and
randomized control trial (RCT), is designed for large numbers of patients in post-
approval research and is a choice study design for comparing the relative strengths
and weaknesses of medical interventions. The objective of this study was to eval-
uate the current landscape of LSTs to capture key themes in the future outlook of
CER. METHODS: A structured abstract review and funnel analysis was conducted
using data available through ClinicalTrials.gov. Using the search terms, “phase IV”,
“post-marketing”, “randomized”, and “multi-centered”, 2230 clinical trials were
filtered with restricted parameters for number of patients (n1000), evidence of
blinding, stated objective of comparative effectiveness, and date of trial initiation.
RESULTS: To gain a perspective on current and future outlook, only trials initiated
between 2009 and 2010 (n10) were assessed in this phase of study. Using the
Pragmatic Explanatory Continuum Indicator Summary (PRECIS) framework origi-
nally developed for pragmatic trials, the analysis revealed an important theme.
When applying key domain criteria – practitioner expertise, treatment flexibility,
eligibility criteria, health outcomes, study duration, intent-to-treat (ITT), and pri-
mary outcome analysis, as defined by the PRECIS framework – less than 50% of the
LST CER trials were designed to measure effectiveness, as opposed to efficacy.
CONCLUSIONS: According to findings, there has been an uptake on the use of LSTs
in investigating the relative effectiveness of interventions. However, considering
the increase in governmental pressure to reduce healthcare spending by improving
quality of treatment; it is important that these LSTs are conducted to truly capture
effectiveness. For that reason, there is need for further research to extract and
develop new frameworks for evaluation.
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OBJECTIVES: To investigate the state of health economic research in Russia avail-
able in the English language by describing the number and characteristics of the
articles, and assessing the quality of these articles.METHODS: The study assessed
the state of health economics and pharmacoeconomics research in Russia. We
conducted a literature search to identify health economics articles pertaining to
Russia. Each article in the final sample was scored by two reviewers independently
using the data-collection form designed for the study. RESULTS: In total, 16 studies
investigating a wide variety of diseases were included in the study. These articles
were published in 15 different journals all based outside of Russia between 1994
and 2009. On average, each article was written by seven authors. Most first authors
had medical/clinical training and resided in the USA (n  8) at the time of publica-
tion of the study. Based on a scale of 1–10,with 10 indicating the highest quality, the
mean quality score for all studies was 8.09 (SD  1.29) and 25% of the articles were
of fair quality (score 5–7). The quality of articles was statistically significantly re-
lated (P  0.05) to the primary health intervention (pharmaceuticals  non-phar-
maceuticals) and primary training of the first author (medical  non-medical).
CONCLUSIONS: The conduct of health economics and pharmacoeconomics research
in Russia in the English language is limited and, on average, the published articles
were of good quality. However, about one-quarter of published articles were of fair
quality. More health economics research in English is warranted in Russia.
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OBJECTIVES: This study compares the patient characteristics, insurance coverage,
disease prevalence, and utilization patterns of inpatient and emergency depart-
ment (ED) services between homeless and non-homeless people using a new data
source that has not been employed in existing studies.METHODS: A retrospective
data analysis was conducted to compare differences in patient characteristics,
insurance coverage, disease prevalence, and utilization patterns between home-
less and non-homeless individuals who visited a hospital or hospital-based emer-
gency department. For each service type, separate rates were created for homeless
and non-homeless populations and then compared. The Healthcare Cost and Uti-
lization Project (HCUP) State Inpatient Databases (SID) and State Emergency De-
partmentDatabases (SEDD) for 2008were used in the analysis. The SID employed in
this study include 15.9 million inpatient hospital discharges from community hos-
pitals in ten states – Arizona, California, Colorado, Florida, Georgia, Massachusetts,
Missouri, NewYork, Pennsylvania andWisconsin. 177,056 of these dischargeswere
homeless patients. The SEDD employed in this study include 23.7 million visits to
ED, where patients were treated and released, from seven states (i.e., Arizona,
Florida, Georgia, Massachusetts, Missouri, New York and Wisconsin). 49,595 of
these visits were homeless patients. RESULTS: The uninsured homeless (non-
homeless) patients were accountable for 28.1% (4.6%) of inpatient admissions and
42.85 (21%) of ED visits. Medicaid covered 48.2% of all inpatient discharges and
34.7% of all ED visits by homeless patients. 73.7% (50.6%) of homeless (non-home-
less) inpatient admissions came through EDs. Homeless patients with mental dis-
orders accounted for 22.4% of all homeless inpatient discharges and 49% of all
homeless ED visits. A majority of the mental disorder diagnosis in both settings of
care were alcohol-related disorders, mood disorders, and schizophrenia.
CONCLUSIONS: The profile of homeless and non-homeless patients differed sig-
nificantly by insurance status and by race in both the inpatient and emergency
department settings.
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OBJECTIVES: Health economies outside Western Europe are increasingly adopting
evidence-based decision-making, but implementation methods differ. Common-
alities in the approach taken in Turkey and Poland nevertheless illustrate the role
of a previously developed reimbursement process in the adoption of HTA. Insights
from this comparisonmay have implications for industry, government and private
reimbursement authorities worldwide. METHODS: Turkey and Poland were se-
lected for comparison due to their relatively recent adoption of HTA within an
established reimbursement system. A total of 18 stakeholderswere interviewed via
telephone interviews to understand current and future utilisation of HTA in reim-
bursement. The study evaluated the impact of the following decision-making do-
mains: clinical differentiation, prioritisation of unmet needs, price, and presenta-
tion requirements (e.g. budget impact analysis). A comparisonwas thenmade on a
rating scale devised to account for these influencing factors. RESULTS: In Turkey
the pharmacoeconomics unit of the Social Security Institute is responsible for
economic evaluation. However the Polish HTA body AHTAPol is more directly in-
volved in the HTA process. All 9 Polish respondents scored high on the influence of
HTA in access decisions while just 2 respondents in Turkey considered HTA to be
extremely influential in reimbursement. However, pricing decisions in both coun-
tries are based on international referencing to varying degrees. CONCLUSIONS:
Despite superficial similarities in the structure of their reimbursement systems,
HTA in Poland is more closely integrated with decision making than in Turkey. At
present HTA plays a formal role in the Turkish system but a negotiation-based
approach remains to customary channel for value arguments. However, the rapid
pace of change in the Turkish reimbursement system suggests the need for further
ongoing research.
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OBJECTIVES: Trends in the use of herbalmedications continue to rise. Pharmacists
have an opportunity to provide consumers with evidence based information. This
study examined pharmacy student’s knowledge regarding herbal medication from
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